Doxycycline taken after sex does not prevent bacterial STIs among cisgender women

Researchers from the University of Washington (UW), Kenya Medical Research Institute (KEMRI), and Hennepin Healthcare Research Institute (HHRI) announced results at CROI from a clinical trial demonstrating that doxycycline taken after sex does not prevent bacterial sexually transmitted infections (STIs) – chlamydia or gonorrhea – among cisgender women.

Related Keywords

Kenya ,Kisumu ,Nyanza ,United States ,France ,Jenell Stewart ,Elizabeth Bukusi ,Emily Henderson ,Senior Principal Clinical Research Scientist ,University Of Washington ,National Institutes Of Health ,University Of Minnesota ,Hennepin Healthcare Research Institute ,Kenya Medical Research Institute ,Study Director ,Infectious Disease Physician ,Hennepin Healthcare ,Principal Investigator ,Kenya Medical Research ,National Institutes ,Anatomy ,Ntibiotic ,Antibiotic Resistance ,Chlamydia ,Clinical Trial ,Efficacy ,Gonorrhea ,Healthcare ,Shiv ,Medical Research ,Prophylaxis ,Research ,Syphilis ,